Cargando…
Shank-associated RH domain interactor signaling in tumorigenesis
Shank-associated RH domain interactor (SHARPIN) is a component of the linear ubiquitin chain activation complex, which is essential for p53 signaling and inflammation. Previous studies have demonstrated that SHARPIN functions in tumor cell survival, growth, invasion and tumorigenesis. These function...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400965/ https://www.ncbi.nlm.nih.gov/pubmed/32782575 http://dx.doi.org/10.3892/ol.2020.11850 |
_version_ | 1783566478450098176 |
---|---|
author | Zeng, Chong Xiong, Dan Zhang, Ketao Yao, Jie |
author_facet | Zeng, Chong Xiong, Dan Zhang, Ketao Yao, Jie |
author_sort | Zeng, Chong |
collection | PubMed |
description | Shank-associated RH domain interactor (SHARPIN) is a component of the linear ubiquitin chain activation complex, which is essential for p53 signaling and inflammation. Previous studies have demonstrated that SHARPIN functions in tumor cell survival, growth, invasion and tumorigenesis. These functions include the regulation of p53 proteins via poly-ubiquitination, interaction with a type II protein arginine methyltransferase 5 in melanoma cells, modulating ras-associated protein-1 through p38 and c-Jun N-terminal kinases/c-Jun signaling, and mediating phosphoinositide 3-kinase/AKT signaling via phosphatase and tensin homologue deleted on chromosome 10. Hence, SHARPIN not only participates in the inflammatory response but also serves a critical role in tumor cells. The present review summarizes the biological functions of the absence or presence of SHARPIN with regard to activating the canonical NF-κB signaling pathway and the effects on p53 and other signaling pathways for the modulation of tumorigenesis. Therefore, this review provides insight into the underlying role and mechanisms of SHARPIN in tumorigenesis, as well as its potential application in cancer therapy. |
format | Online Article Text |
id | pubmed-7400965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-74009652020-08-10 Shank-associated RH domain interactor signaling in tumorigenesis Zeng, Chong Xiong, Dan Zhang, Ketao Yao, Jie Oncol Lett Review Shank-associated RH domain interactor (SHARPIN) is a component of the linear ubiquitin chain activation complex, which is essential for p53 signaling and inflammation. Previous studies have demonstrated that SHARPIN functions in tumor cell survival, growth, invasion and tumorigenesis. These functions include the regulation of p53 proteins via poly-ubiquitination, interaction with a type II protein arginine methyltransferase 5 in melanoma cells, modulating ras-associated protein-1 through p38 and c-Jun N-terminal kinases/c-Jun signaling, and mediating phosphoinositide 3-kinase/AKT signaling via phosphatase and tensin homologue deleted on chromosome 10. Hence, SHARPIN not only participates in the inflammatory response but also serves a critical role in tumor cells. The present review summarizes the biological functions of the absence or presence of SHARPIN with regard to activating the canonical NF-κB signaling pathway and the effects on p53 and other signaling pathways for the modulation of tumorigenesis. Therefore, this review provides insight into the underlying role and mechanisms of SHARPIN in tumorigenesis, as well as its potential application in cancer therapy. D.A. Spandidos 2020-09 2020-07-09 /pmc/articles/PMC7400965/ /pubmed/32782575 http://dx.doi.org/10.3892/ol.2020.11850 Text en Copyright: © Zeng et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Zeng, Chong Xiong, Dan Zhang, Ketao Yao, Jie Shank-associated RH domain interactor signaling in tumorigenesis |
title | Shank-associated RH domain interactor signaling in tumorigenesis |
title_full | Shank-associated RH domain interactor signaling in tumorigenesis |
title_fullStr | Shank-associated RH domain interactor signaling in tumorigenesis |
title_full_unstemmed | Shank-associated RH domain interactor signaling in tumorigenesis |
title_short | Shank-associated RH domain interactor signaling in tumorigenesis |
title_sort | shank-associated rh domain interactor signaling in tumorigenesis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400965/ https://www.ncbi.nlm.nih.gov/pubmed/32782575 http://dx.doi.org/10.3892/ol.2020.11850 |
work_keys_str_mv | AT zengchong shankassociatedrhdomaininteractorsignalingintumorigenesis AT xiongdan shankassociatedrhdomaininteractorsignalingintumorigenesis AT zhangketao shankassociatedrhdomaininteractorsignalingintumorigenesis AT yaojie shankassociatedrhdomaininteractorsignalingintumorigenesis |